Healthcare / Diagnostics & Research

Agilent Technologies, Inc. (A)

$135.05
-0.68%
$38.2B
Market Cap
27.3
P/E Ratio
1.22
Beta
0.75%
Dividend Yield
Piotroski 5/9Altman Z 4.6 SafeBeneish M -2.46 CleanROIC−WACC -0.3%

Quantitative Summary

Deterministic

At 27.3x earnings — a 58% discount to the sector average of 65.2x — A is in the lower valuation range. Financial health is average: Piotroski 5/9, Altman Z 4.6. DCF fair value of $50 implies 57% downside based on model assumptions.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

Agilent Technologies presents a fundamental profile characterized by robust profitability metrics that mask underlying capital efficiency constraints. While the DuPont decomposition reveals strong earnings quality driven primarily by an 18.8% net margin, this leverage is offset by a modest asset turnover of 0.55x and limited financial gearing at 1.89x. The critical structural weakness emerges in the return on invested capital (ROIC) of 11.8%, which falls below the weighted average cost of capital (WACC) of 12.1%, resulting in a negative spread that erodes long-term shareholder value despite a healthy Piotroski F-Score of 5/9 and an Altman Z-Score of 4.5 indicating solvency stability. The Beneish M-Score of -2.46 further suggests management earnings are unlikely to be manipulated, yet the negative ROIC-WACC dynamic implies that current growth strategies may not generate sufficient economic returns relative to capital deployment costs.

Valuation multiples reflect this tension between historical performance and future expectations; trading at a P/E of 25.5x, the stock commands a discount of approximately 17% versus the sector average of 30.8x. However, discounted cash flow analysis suggests significant downside pressure, with a fair value estimate of $50 implying -55.9% upside from current levels if long-term free cash flow growth materializes at the projected 16.5% annualized rate over the next decade. This discrepancy indicates the market may be pricing in lower persistence for these margins or anticipating a compression in asset turnover that would further depress ROIC, creating a valuation gap between fundamental earnings power and intrinsic worth.

Risk-adjusted return metrics highlight a distinct divergence from traditional factor premiums. The stock exhibits a substantial negative Fama-French alpha of -21.44% annually, signaling underperformance relative to its risk profile over the measured period. This underperformance is exacerbated by a Value Factor (HML) tilt of -0.179 and neutral Profitability Factor exposure (RMW: 0.013), suggesting the equity has behaved more like a growth asset than a value proxy despite trading below sector peers. With insider flow remaining neutral over the last ninety days, there is no immediate signal of management conviction or distress to offset these statistical headwinds, leaving investors to weigh whether current pricing adequately compensates for the negative capital efficiency spread and persistent factor underperformance.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive
Market Price
$135.05
Fair Value
$50
Implied Upside
-63.2%
$50IMPLIED FAIR VALUEOVERVALUEDOVERUNDER
Growth Rate (Y1–5)7%
-10%20%50%
Discount Rate (WACC)12.1%
5%12.5%20%

5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.

Reverse DCFMarket-Implied
16.9%annual FCF growth priced in at $135.05

The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 7% YoY revenue.

Sensitivity Matrix

TG ↓ / WACC →10.1%12.1%14.1%
2%$59$46$38
3%$66$50$40
4%$75$55$43

Center = base case. Green = >10% upside, Red = >10% downside vs $135.05.

Pre-computed DCF: WACC=12.1%, terminal growth 3%. Fair value $50 (-57.1%). Not investment advice.

Valuation Context

27.3x
A P/E
65.2x
Sector Avg
24.3x
5Y Avg P/E
-58%
vs Sector

Currently trading 4% above its 5-year average P/E of 24.3x.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Technical Setup

AI Generated

Agilent Technologies, Inc. is currently trading at $114.96 within the Healthcare sector, a level that warrants examination against its established moving average envelope to gauge relative positioning. While specific short-term and long-term moving averages are not explicitly detailed in this snapshot, the proximity of the current price to these dynamic support and resistance bands serves as the primary indicator for potential mean-reversion dynamics. If the stock has recently tested the lower boundary of a defined channel or is hovering near a key simple moving average after a period of consolidation, it may suggest that statistical probabilities favor a return toward the central trend line rather than an immediate breakout or breakdown. The absence of extreme deviations from these historical averages often signals a market equilibrium where volatility contracts, potentially setting the stage for low-risk entry points if the price dips further to established support levels. Conversely, significant distance above or below the mean would imply higher momentum but also increased exposure to correction risks as the asset seeks alignment with its long-term trajectory. In this neutral technical context, the $114.96 mark acts as a pivot point where traders might monitor whether subsequent price action confirms a continuation of the current trend or triggers a reversion toward the statistical average defined by recent trading history.

RSI (14)
SMA 50
SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
4.6
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.46
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

52.4%
Gross Margin
18.8%
Net Margin
11.8%
ROIC
12.1%
WACC
ROIC − WACC Spread: -0.3%— Negative spread.
+6.7%
Revenue Growth (YoY)
+1.1%
Earnings Growth (YoY)
1.2B
Free Cash Flow
24%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

18.8%
Net Profit Margin
NI ÷ Revenue
×
0.55x
Asset Turnover
Revenue ÷ Assets
×
1.89x
Equity Multiplier
Assets ÷ Equity
=
19.3%
Return on Equity
✅ ROE driven primarily by strong profit margins — a sign of pricing power.

Balance Sheet Health

0.89x
Debt / Equity
1.96x
Current Ratio
13.8x
Interest Coverage
0.7x
Net Debt / EBITDA
3.41%
FCF Yield
1.8B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $1.26
Act: $1.31
+3.6%
Q3
✓ Beat
Est: $1.37
Act: $1.37
+0.2%
Q2
✓ Beat
Est: $1.58
Act: $1.59
+0.4%
Q1
✗ Miss
Est: $1.37
Act: $1.36
-0.6%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Dividend History

$0.2550
Latest Dividend
$0.74
2025 Total
-22.2%
YoY Growth
Annual Dividends per Share
$0.36
2016
$0.55
2017
$0.61
2018
$0.67
2019
$0.54
2020
$0.78
2021
$1.06
2022
$0.91
2023
$0.96
2024
$0.74
2025
$0.51
2026
DateAmountChange
2026-03-31$0.25500.0%
2026-01-06$0.2550+2.8%
2025-09-30$0.24800.0%
2025-07-01$0.24800.0%
2025-04-01$0.24800.0%
2024-12-31$0.2480+5.1%
2024-10-01$0.23600.0%
2024-07-02$0.23600.0%
2024-04-01$0.23600.0%
2023-12-29$0.2360+4.9%
2023-10-02$0.22500.0%
2023-06-30$0.22500.0%
Stock Splits
2014-11-03: 1.398:1

Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.

Risk Profile

31.2%
Annual Volatility
0.32
Sharpe (1Y)
-29.8%
Max Drawdown (5Y)

Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fama-French 5-Factor Exposure

Academic factor model decomposition — what's really driving this stock's returns.

1.02
Market β
Mkt-RF
+0.599
Size (SMB)
Small-cap tilt
-0.179
Value (HML)
Growth tilt
+0.013
Profit (RMW)
Neutral
+1.038
Invest (CMA)
Conservative
Alpha (annual): -21.44%
R²: 52.7%of variance explained by 5 factors

Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.

Fundamentals

20.5
Forward P/E
1.21
PEG Ratio
5.37
Price/Book
2M
Avg Volume
$160.27
52W High
$108.35
52W Low
51%
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$5.0B
Tracked Passive Exposure
8
ETFs Holding A
0.08%
Avg Weight in ETFs
$6.2T
Total ETF AUM

When investors buy or sell ETFs like MOAT or VOT, the fund manager is mechanically forced to buy or sell A shares regardless of Agilent Technologies, Inc.'s individual fundamentals. We estimate $5.0B of passive capital is structurally linked to A through 8 tracked ETFs. This substantial passive exposure means that ETF inflows and outflows — not company fundamentals — can dominate daily volume on this stock.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in Agilent Technologies, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.

A Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
AEpicenterVTIETFVOOETFIVVETFLLYLow RiskLLYLow RiskJNJLow RiskJNJLow RiskABBVMed Risk
A Price Drop (%)0

If Agilent Technologies, Inc. (A) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ELI LILLY + CO (LLY) as the most exposed collateral stock, sharing 1 ETFs with A. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 29 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

A Ownership Dynamics

Passive funds hold 1 in every 6 A shares, reducing daily market volatility.

Ticker
A
Total Shares
282M
ETF Lock-Up
15.6%
Display Mode
Total Float Impact
15.6%Locked Float

Agilent Technologies, Inc. (A) exerts notable gravity on the passive index market, currently representing 1.3% of the MOAT (MOAT) and 0.8% of the VOT (VOT). Across 29 tracked ETFs, approximately 44M shares (15.6% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.

Float lock-up computed from 29 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

A Institutional Volume Profile

252-day volume distribution by price level. The Point of Control (POC) marks the price where the most institutional volume transacted — an implicit support/resistance floor.

TICKER
A
PRICE
$135.05
FLOOR (POC)
$114.81
STRENGTH
High
$110$11210%$115POC 13%$11710%$12011%$123$1257%$128$130$133$135$135.05$1387%$141$143$146$148$151$154$156$159
Focus Zone
Point of Control (POC) Support (below price) Resistance (above price) Current Price

The highest-volume price zone for Agilent Technologies, Inc. over the past year sits near $114.81 (13% of 252-day volume). The current price of $135.05 trades 17.6% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target. The highly concentrated volume profile (13% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.

Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.

A Capital Efficiency

How efficiently does Agilent Technologies, Inc. convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$1.2B
EBITDA
$1.8B
FCF Conversion
63%
Reinvestment Rate
37%
63% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
11.8%
ROIC − WACC Spread
-0.3%

Agilent Technologies, Inc. converts 63% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-0.3%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-04-2050$121.87$6,093.5
2026-04-17471$118.25$55,695.75
2026-04-07429$114.84$49,266.36
2026-04-061$115.48$115.48
2026-03-262,320$112.98$262,113.6
2026-03-2528$114.20$3,197.6
2026-03-23135,809$111.30$15.1M
2026-03-025$121.38$606.9
2026-02-26169$124.72$21,077.68
2026-02-1946$126.94$5,839.24
2026-02-03119$135.39$16,111.41
2026-01-081$147.81$147.81
2025-12-225,226$137.24$717,216.24
2025-12-17702$139.19$97,711.38
2025-12-11192$143.47$27,546.24
2025-11-2043$144.40$6,209.2
2025-11-189$144.52$1,300.68
2025-11-1313$151.52$1,969.76
2025-10-2939$145.85$5,688.15
2025-10-2321$145.87$3,063.27
2025-10-212,356$143.00$336,908
2025-10-201$141.92$141.92
2025-10-1579$138.04$10,905.16
2025-10-0634,402$141.64$4.9M

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Price Correlations

Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.

Peer252-Day (1Y)126-Day (6M)Direction
WTGXXNaNNaN
MTD0.8280.757High co-movement
DHR0.7840.693High co-movement
TMO0.7830.694High co-movement
WAT0.7310.599High co-movement
IQV0.6660.534Moderate
NDSN0.6230.549Moderate
GEHC0.6030.564Moderate
ILMN0.5850.429Moderate
PFE0.5710.477Moderate

Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.

Compare A to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.